Medinfar Manufacturing, S.A. (Manufacturing, packaging)

The drug is used for the treatment of epilepsy. It is prescribed both as monotherapy for partial seizures in adults and adolescents aged 16 years and older, and as adjunctive therapy for children (from 1 month of age) and adults for various forms of epileptic seizures, including myoclonic seizures and generalized seizures.

Dosage form: solution, oral

ATC: N03AX14